Amedisys (NASDAQ:AMED) Earns "Neutral" Rating from Cantor Fitzgerald

Amedisys (NASDAQ:AMED - Get Free Report)'s stock had its "neutral" rating reaffirmed by stock analysts at Cantor Fitzgerald in a report issued on Thursday, Benzinga reports. They presently have a $101.00 price target on the health services provider's stock. Cantor Fitzgerald's price objective suggests a potential upside of 10.79% from the stock's previous close.

Several other equities analysts have also weighed in on the stock. Raymond James reaffirmed a "market perform" rating on shares of Amedisys in a research report on Tuesday, March 26th. Royal Bank of Canada raised their price objective on shares of Amedisys from $97.00 to $100.00 and gave the company an "outperform" rating in a research report on Monday, March 25th. Finally, StockNews.com began coverage on Amedisys in a report on Monday, April 8th. They set a "buy" rating on the stock. Seven research analysts have rated the stock with a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat.com, Amedisys has a consensus rating of "Hold" and an average price target of $97.50.

Amedisys Stock Up 0.1 %

AMED traded up $0.11 during midday trading on Thursday, hitting $91.16. 236,321 shares of the company's stock traded hands, compared to its average volume of 277,878. The company has a market cap of $2.98 billion, a PE ratio of -294.06, a price-to-earnings-growth ratio of 4.29 and a beta of 0.86. The stock's fifty day simple moving average is $92.57 and its 200-day simple moving average is $93.35. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.05 and a quick ratio of 1.05. Amedisys has a one year low of $73.10 and a one year high of $96.44.

Amedisys (NASDAQ:AMED - Get Free Report) last issued its quarterly earnings data on Wednesday, April 24th. The health services provider reported $1.03 earnings per share for the quarter, beating the consensus estimate of $1.02 by $0.01. The firm had revenue of $571.41 million for the quarter, compared to analyst estimates of $565.38 million. Amedisys had a negative net margin of 0.44% and a positive return on equity of 12.76%. The company's revenue for the quarter was up 2.7% on a year-over-year basis. During the same quarter last year, the firm earned $1.00 earnings per share. As a group, equities analysts anticipate that Amedisys will post 4.54 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Amedisys

Institutional investors and hedge funds have recently bought and sold shares of the stock. Calamos Advisors LLC bought a new position in Amedisys during the fourth quarter worth $23,015,000. SG Americas Securities LLC increased its position in Amedisys by 181.1% during the fourth quarter. SG Americas Securities LLC now owns 63,953 shares of the health services provider's stock worth $6,079,000 after acquiring an additional 41,206 shares during the period. Wolverine Asset Management LLC increased its position in Amedisys by 13.9% during the fourth quarter. Wolverine Asset Management LLC now owns 35,181 shares of the health services provider's stock worth $3,344,000 after acquiring an additional 4,299 shares during the period. Bank of Nova Scotia bought a new position in Amedisys during the third quarter worth $26,671,000. Finally, Hsbc Holdings PLC increased its position in Amedisys by 184.9% during the third quarter. Hsbc Holdings PLC now owns 110,479 shares of the health services provider's stock worth $10,327,000 after acquiring an additional 71,705 shares during the period. Institutional investors own 94.36% of the company's stock.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.